These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36789402)
1. Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19-9, CA15-3, CA125, PSA, HE4, Cyfra 21-1, and ProGRP) in primary care centers in Korea: A cross-sectional retrospective study. Nah EH; Cho S; Park H; Kim S; Kwon E; Cho HI Health Sci Rep; 2023 Feb; 6(2):e1107. PubMed ID: 36789402 [TBL] [Abstract][Full Text] [Related]
2. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
3. Establishment of Reference Intervals of Cytokeratin 19 Fragment Antigen 21-1 in Korean Adults. Yoon S; Lim YK; Kim HR; Lee MK; Kweon OJ Ann Lab Med; 2023 Jan; 43(1):82-85. PubMed ID: 36045060 [TBL] [Abstract][Full Text] [Related]
4. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. Bevilacqua V; Chan MK; Chen Y; Armbruster D; Schodin B; Adeli K Clin Chem; 2014 Dec; 60(12):1532-42. PubMed ID: 25261558 [TBL] [Abstract][Full Text] [Related]
5. [Establishment of reference intervals of tumor markers in Korean adults]. Woo HY; Kim YJ; Park H Korean J Lab Med; 2008 Jun; 28(3):179-84. PubMed ID: 18594168 [TBL] [Abstract][Full Text] [Related]
6. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data. Miao Q; Lei S; Chen F; Niu Q; Luo H; Cai B BMC Cancer; 2024 May; 24(1):657. PubMed ID: 38811867 [TBL] [Abstract][Full Text] [Related]
7. Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China. Li Y; Li M; Zhang Y; Zhou J; Jiang L; Yang C; Li G; Qu W; Li X; Chen Y; Chen Q; Wang W; Wang S; Liang Xing J; Huang H J Clin Lab Anal; 2021 Jun; 35(6):e23816. PubMed ID: 33982344 [TBL] [Abstract][Full Text] [Related]
8. Establishment of tumor marker reference intervals for different age and gender groups in the healthy population of South China. Meng Y; Li X; Li H; Gu B Scand J Clin Lab Invest; 2024 Oct; 84(6):398-404. PubMed ID: 39283251 [TBL] [Abstract][Full Text] [Related]
9. Reference intervals for gastrointestinal tumor markers (AFP, CEA, CA199 and CA724) in healthy adults of Han nationality in Chongqing by Roche ECLIA system. Yu H Scand J Clin Lab Invest; 2019 Nov; 79(7):484-490. PubMed ID: 31599689 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy. Bozkurt M; Yumru AE; Aral I Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047 [TBL] [Abstract][Full Text] [Related]
12. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Chen Z; Wang Y; Fang M Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123 [TBL] [Abstract][Full Text] [Related]
13. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229 [TBL] [Abstract][Full Text] [Related]
14. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer. Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590 [TBL] [Abstract][Full Text] [Related]
15. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study. van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453 [TBL] [Abstract][Full Text] [Related]
17. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay. Yang J; Sa M; Huang M; Yang J; Xiang Z; Liu B; Tang A Clin Biochem; 2013 Nov; 46(16-17):1705-8. PubMed ID: 24012857 [TBL] [Abstract][Full Text] [Related]
18. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents. Higgins V; Fung AWS; Chan MK; Macri J; Adeli K Clin Chem Lab Med; 2018 Jan; 56(2):327-340. PubMed ID: 28723610 [TBL] [Abstract][Full Text] [Related]
19. Indicators of inappropriate tumour marker use through the mining of electronic health records. Gion M; Cardinali G; Trevisiol C; Zappa M; Rainato G; Fabricio ASC J Eval Clin Pract; 2017 Aug; 23(4):895-902. PubMed ID: 28503788 [TBL] [Abstract][Full Text] [Related]
20. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study. Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]